Cell and gene therapy CRO market Professional Survey Report by 2035

The “Cell and Gene Therapy CROs Market, 2022-2035” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”.

Key Inclusions
 A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, area of expertise (cell therapy (stem cells, T cells, dendritic cells, NK cells and tumor cells) and gene therapy), scale of operation (discovery, preclinical, clinical and commercial) and types of services offered, including [A] preclinical services (bioanalytical services, in-vivo studies, pharmacokinetic and ADME services, preclinical safety studies, toxicology studies and other preclinical services), [B] clinical services (clinical research monitoring, clinical trial management/ clinical project management, data management, safety and pharmacovigilance, and other clinical services), [C] regulatory services (GAP analysis, IND preparation, legal representation and technical dossier submission) and [D] general support services (biostatistics, consulting, post-market assessment, re-imbursement and training).
 A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies. In addition, it includes information on various factors that drive developers towards outsourcing and key parameters that sponsors must consider while choosing CROs at each phase of drug development process.
 Elaborate profiles of key industry players (very large and large companies) based in North America, Europe and Asia-Pacific that offer contract research services for both cell and gene therapies across both preclinical and clinical scales of operation. Each profile features a brief overview of the company, along with details related to its cell and gene therapies-related service portfolio, recent developments, and an informed future outlook.
 A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies (in terms of their expertise across various services related to the development of cell and gene therapies). The analysis allows companies to compare their existing capabilities within and beyond their peer groups and identify opportunities to gain a competitive edge in the industry.
 An analysis of the recent collaborations within the cell and gene therapy contract research industry, based on several relevant parameters, such as year of partnership, type of partnership, area of expertise, most active players (in terms of number of deals inked) and regional distribution of partnership activity that have been undertaken in this domain, during the period 2015-2022.
 A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022, based on several parameters, such as year, type of agreement, area of expertise, geographical location of the companies and key value drivers.
 A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015, and offering a means for other industry stakeholders to identify potential acquisition targets.
 A list of over 310 cell therapy developers that are anticipated to partner with cell therapy CROs. These players have been shortlisted based on several relevant parameters, such as developer strength (based on company's size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development), and availability of other cell therapy capabilities.
 An in-depth analysis of nearly 235 gene therapy developers that are anticipated to partner with gene therapy CROs and have been shortlisted on the basis of several relevant parameters, such as developer strength (based on company's size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development) and availability of other gene therapy capabilities.
 An in-depth analysis of completed, ongoing, and planned clinical studies of various cell and gene therapies, based on several relevant parameters, such as trial registration year, phase of development, current trial status, enrolled patient population, study design, leading industry players (in terms of number of trials conducted), therapeutic area and key geographical regions.
 A detailed analysis of the total cost of ownership for large / very large cell and gene therapy contract research organizations. It features an informed estimate of direct and indirect expenses taking into consideration various relevant parameters, over a span of 20 years.
 A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry's evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Area of Expertise
 Cell Therapy
 Gene Therapy

 Scale of Operation
 Preclinical
 Clinical
 Drug Discovery

 Therapeutic Area
 Oncological Disorders
 Neurological Disorders
 Cardiovascular Disorders
 Infectious Diseases
 Metabolic Disorders
 Autoimmune Disorders
 Blood Disorders
 Rare / Genetic Disorders
 Ophthalmic Disorders
 Other disorders

 Analysis by Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa

Key Questions Answered
 Who are the leading players engaged in offering cell and gene therapy related research services?
 Which business models are most commonly adopted by biopharmaceutical developers for outsourcing cell and gene therapies?
 Which partnership models are commonly adopted by stakeholders engaged in this industry?
 What are the key value drivers of the merger and acquisition activity in the cell and gene therapy market?
 Which players are likely to partner with cell and gene therapy CROs?
 Which regions emerged as the key hubs for carrying out clinical studies focused on cell and gene therapies?
 How is the current and future market opportunity likely to be distributed across key market segments?
 What are the anticipated future trends related to cell and gene therapy related research services?

To view more details on this report, click on the link:
[a]https%3A%2F%2Fwww.rootsanalysis.com%2Freports%2Fview_document%2Fcell-and-gene-therapy-cros-market%2F230.html[/a]

News article
Non-viral Drug Delivery Systems Market

Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Advancements in Automation of Processes: Key Value Driver for Escalated Interest in Cell Therapies Manufacturing Domain

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnsonrootsanalysis.com

#cellandgenetherapycromarket #cellandgenetherapycromarketgrowth #geneandcelltherapy #cellandgenetherapycro #cellandgenetherapies

Lab Automation market Analysis and Trends by 2023-2035

The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems.

Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035”

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.
 A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength.
 Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
 A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
 An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
 A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s).
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Stage of Automation
 Pre-Analytical Stage
 Analytical Stage
 Post-Analytical Stage
 Total Lab Automation
 Type of Instrument
 Automated Liquid Handling Systems
 Automated Microplate Readers
 Automated Sampling Systems
 Analyzers
 Automated Storage and Retrieval Systems (ASRS)
 Other Instruments
 End-User
 Pharmaceutical and Biotechnology Companies
 Research and Diagnostic Laboratories
 Other End-Users
 Key Geographical Region
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

Key companies covered in the report
 Abbott
 Anton Paar
 BD
 Beckman Coulter
 ERWEKA
 Leuze
 Ortho Clinical Diagnostics
 Pall Corporation
 PerkinElmer
 Roche Diagnostics
 Siemens Healthineers
 SYSTAG

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/lab-automati

News article
Digital Biomanufacturing Market

Learn from experts: do you know about these emerging industry trends?
SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases
Novel Cell Cytometers: Need of the Hour

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnsonrootsanalysis.com


#labautomationmarket #labautomationmarketgrowth #labautomation #laboratoryautomation #laboratoryautomationmarket

Quantum Computing market, Industry Analysis, and Forecast to 2035

Upon realizing the numerous benefits of quantum computing, stakeholders in the pharmaceutical industry are currently exploring its implementation across drug discovery and development in order to minimize the associated cost and time investment

Roots Analysis has announced the addition of “Quantum Computing in Drug Discovery Services Market, 2023-2035” report to its list of offerings.

The report features an extensive study on the extensive study of the current landscape and the likely future potential of quantum computing in drug discovery services market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field. In addition to other elements, the study includes:

 An executive summary of the insights captured during our research. It offers a high-level view on the current state of quantum computing in drug discovery services market and its likely evolution in the short to mid and long term.
 A general overview of quantum computing in drug discovery services, along with information on its types and applications across various industries. It also highlights the applications of quantum computing, specifically related to drug discovery. Further, the chapter features a discussion on the challenges, key growth drivers, and future perspectives.
 A detailed assessment of the overall market landscape of quantum computing software providers, based on several relevant parameters, including year of establishment, company size, location of headquarters, business capabilities, platform capabilities, type of drug discovery service(s) offered, type of molecule(s) supported, compatible computational approaches, end user(s) and therapeutic area(s).
 A detailed competitiveness analysis of quantum computing services providers based on company strength, portfolio strength and portfolio diversity.
 Elaborate profiles of quantum computing software providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.
 A detailed assessment of the overall market landscape of quantum computing hardware providers, based on several parameters including year of establishment, company size, location of headquarters, type of offering(s), data storage on cloud and compatible computational approaches.
 Detailed profiles of quantum computing hardware providers. Each profile includes a brief overview of the company, financial information (if available), details on service portfolio, recent developments and an informed future outlook.
 A detailed review of over 170 academic grants focused on quantum computing in drug discovery, based on several relevant parameters, such as year of grants awarded, amount awarded, support period, type of study section, administering institute center, type of grant, activity code, funding mechanism and amount granted, administering institute and support period, prominent program officers (by number of grants), location of recipient organizations, popular recipient organizations, organization type and amount granted to popular recipient.
 A detailed analysis of recent partnerships inked between stakeholders engaged in this domain, since 2017, based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships), and regional distribution of partnership activity in this domain.
 A use case study highlighting the applications of quantum computing across various industries, such as chemical industry, cybersecurity, financial modeling, space sciences, oil and gas industry and weather forecasting, and its likely evolution in the foreseen future.

 A qualitative analysis, highlighting the five competitive forces prevalent in this domain, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute product and rivalry among existing competitors.
 A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software providers to shift towards a blue ocean strategic market.
 One of the key objectives of the report was to estimate the current opportunity and future growth potential of quantum computing in drug discovery services market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as drug discovery services offered, therapeutic area and key geographical regions. In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.

By 2035, financial opportunity within the tissue engineering-based regeneration devices has been analyzed across the following segments:

 Type of Drug Discovery Services
 Target Identification / Validation
 Hit Generation / Lead Identification
 Lead Optimization

 Therapeutic Area
 Cardiovascular Disorders
 CNS Disorders
 Dermatological Disorders
 Endocrine Disorders
 Gastrointestinal Disorders
 Immunological Disorders
 Infectious Diseases
 Musculoskeletal Disorders
 Oncological Disorders
 Respiratory Disorders
 Others

 Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 MENA

Key Companies covered in the report
 Accenture
 Amazon Web Services
 Atos
 Fujitsu
 Huawei
 IBM
 Microsoft
 Xanadu
 XtalPi

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/quantum-comp

News article
Genotoxicity Testing and Mutagenicity Testing Services Market


Learn from experts: do you know about these emerging industry trends?
Liposomes Development: Service Providers Landscape

mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule


About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnsonrootsanalysis.com


#quantumcomputingcompanies #quantumcomputingreport #quantumcomputingsoftware

mRNA therapeutics and Vaccines market Professional Survey Report by 2035

The mRNA therapeutics and vaccines market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors.

This can be attributed to the various benefits offered by these therapeutic modalities, such as ease of administration, higher biological efficacy, enhanced potent immunogenicity and versatile delivery platforms at reduced toxicity levels.

The financial opportunity within the mRNA therapeutics and mRNA vaccines market has been analyzed across the following segments:

 Routes of Administration
 Intradermal
 Intravenous
 Intranasal
 Others

 Therapeutic Area
 Infectious Diseases
 Oncological Disorders
 Other Disorders

Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

The mRNA Therapeutics and mRNA Vaccine Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
 Arcturus Therapeutics
 BioNTech and Pfizer
 CureVac
 Gennova
 Moderna
 Walvax

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Competitive Landscape

6. Company Competitiveness Analysis

7. Drug Profiles

8. Big Pharma Initiatives

9. Start-Up Health Indexing

10. Clinical Trial Analysis

11. Partnerships and Collaborations

12. Funding and Investment Analysis

13. Patent Analysis

14. Market Forecast and Opportunity Analysis

15. Market Forecast and Opportunity Analysis

16. Conclusion

17. Appendix 1: Tabulated Data

18. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/mrna-therape

News article
Biopharmaceutical Filtration Market

Learn from experts: do you know about these emerging industry trends?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnsonrootsanalysis.com


#mrnatherapeuticsandvaccinesmarket #mrnatherapeuticsandvaccinesmarketsize #mrnatherapeutics #mrnavaccine #mrnavaccinemarket

Dental 3D Printing market Size, Share, Trends by 2035

The “Dental 3D Printing Market, 2023-2035” report features an extensive study of the current market landscape and future potential of the dental 3D printing market over the next decade.

Key Inclusions
 A general overview of dental 3D printing, highlighting details on technologies used in dental 3D printers and applications of 3D printing in the dental industry. It also presents information on the advantages and limitations associated with dental 3D printing. Additionally, it features a discussion on the future prospects within this domain.
 A detailed assessment of the overall market landscape of around 230 dental 3D printers, based on several relevant parameters, such as type of product(s) printed (crowns / bridges / dentures, working models, surgical guides, aligners/ hawley retainers/ brackets, implants, gingival masks and others), application area(s) (prosthodontics, orthodontics and dental implants), type of printing technology (digital light processing (DLP), stereolithography (SLA), liquid crystal display (LCD), selective laser melting (SLM), radio-frequency identification (RFID), direct metal laser sintering (DMLS), masked stereolithography (MSLA), carbon digital light synthesis (Carbon DLS), polyjet, melted extrusion modelling (MEM), powder bed fusion, subpixel micro scan (SMS), multijet and others), type of printing process (vat photopolymerization, powder bed fusion, polyjet, material extrusion and others), type of printing material(s) (resins, polymers, metals, ceramics and others / unspecified), printer wavelength (upto 405 nm and above 405 nm), type of connectivity (ethernet, USB, Wi-Fi, cloud and others / undisclosed), printing speed (below 50 mm/hour, 50-100 mm/hour, 101-150 mm/hour, 151-200 mm/hour, 201-25 mm/hour, 251-300 mm/hour and others), layer thickness of printed products (below 50 µm, 50-100 µm, 101-150 µm, 151-200 µm and above 200 µm), printer resolution (below 50 µm, 50-100 µm, above 100 µm and others) and printer price (below USD 10,000, USD 10,000-50,000, USD 50,000-100,000, above USD 100,000 and undisclosed). In addition, it provides details on the dental 3D printer manufacturers, along with analysis based on their year of establishment, company size, location of headquarters and leading players (in terms of number of dental 3D printers offered).
 A product competitiveness analysis of the dental 3D printers, based on supplier power (in terms of the experience of the developer) and product competitiveness (in terms of number of products printed, application area, printing process, type of printing material, wavelength, type of connectivity, layer thickness of printed products, resolution and printer price).
 Elaborate profiles of the prominent players (shortlisted based on proprietary scoring criteria) engaged in dental 3D printing domain. Each company profile features a brief overview of the company, details related to its dental 3D printer portfolio, recent developments and an informed future outlook.
 An analysis of partnerships that have been inked by dental 3D printer manufacturers engaged in this domain, since 2018, covering instances of product integration agreements, distribution agreements, technology utilization agreements, acquisitions and mergers, commercialization agreements, service alliances, product development agreements, technology integration agreements, research and development agreements and others. Further, the partnership activity in this domain has been analyzed based on several relevant parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships) and regional distribution of collaborations.
 An in-depth analysis of the patents that have been filed / granted related to dental 3D printing, since 2019, taking into consideration several relevant parameters, such as type of patent, publication year, application year, geographical location, CPC symbols, type of applicant, patent age and leading players (in terms of number of patents filed / granted). It also features a patent benchmarking analysis and a detailed patent characteristics and patent valuation analysis.
 A Bowman's strategy clock framework to understand the pricing strategy of the dental 3D printer offered by a company, along with its competitive position in the market. In addition, it presents the equation devised to calculate the likely price of dental 3D printers based upon their characteristics.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
 Type of Printing Technology
 VAT Polymerization Technology
 Powder Bed Fusion Technology
 Polyjet Technology
 Metal Extrusion Technology
 Other Technologies

 Application Area
 Prosthodontics
 Orthodontics
 Dental Implants
 Other Applications

 Type of Printing Material
 Resins
 Plastics
 Metals
 Metals
 Other Material

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa
 Rest of the World

Key Questions Answered
 How is 3D printing used in the dental industry?
 How many dental 3D printers are currently available in the market?
 Which 3D printers are best for dentistry?
 What is the growth rate of the dental 3D printing market?
 Which region captures the largest share of the dental 3D printing market?
 Which printing technology is widely used in the dental 3D printers?
 Which application area currently holds the largest share in the dental 3D printing market?
 What are the partnerships and collaborations trend in the dental 3D printing domain?
 How many patents have been filed / granted related to dental 3D printing in the recent years?

Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/....reports/dental-3d-pr

You may also be interested in the following titles:
Nanoparticle Formulation Market
Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space
Viral Clearance and Testing Services Market
Roots Analysis Consulting - the preferred research partner for global firms

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnsonrootsanalysis.com


#dental3dprintingmarket #dental3dprintingmarketsize #dental3dprinting #dental3dprinter #dental3dprinters